Piramal Pharma (PPLPHARMA) — Financial Results

📢 Key Event
Conference call scheduled for Q1 FY2027 results discussion

💡 Investor Takeaway
The call will provide insights into Q1 FY2027 results and strategic progress.

Piramal Pharma Limited announced a conference call on July 30, 2026, to discuss Q1 FY2027 results, inviting investors and analysts to review its financial performance and strategic updates.

📄 View Original Announcement (PDF)

📊 Stock Analysis — PPLPHARMA ✨ Ask AI About This

About Piramal Pharma Limited (PPLPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹23,244.56 Cr P/E: 582.9

View full PPLPHARMA stock details →

📡 Get AI alerts when PPLPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track PPLPHARMA — Free

💡 Ask AI about this filing

"What is the expected revenue growth YoY?" "How does margin guidance compare to peers?" "When will full FY2027 guidance be provided?"

Ask AI Free →

📊 More PPLPHARMA filings

See all PPLPHARMA filings →

🔥 Also filed on 20 July 2026

ANDHRAPAP ANDHRA PAPER LIMITED Annual Report CANHLIFE Canara HSBC Life Insurance Company Limited Financial Results CANBK Canara Bank Corporate Action KROSS Kross Limited Financial Results IDFCFIRSTB IDFC First Bank Limited Financial Results J&KBANK The Jammu & Kashmir Bank Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when PPLPHARMA files new disclosures

Track PPLPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.